ClinConnect ClinConnect Logo
Search / Trial NCT03463668

Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years

Launched by INSTITUT PAOLI-CALMETTES · Mar 12, 2018

Trial Information

Current as of July 05, 2025

Recruiting

Keywords

Duodenal Stenosis Pyloric Stenosis Digestive Neoplasias Non Digestive Neoplasias Duodenal Prosthesis

ClinConnect Summary

This clinical trial is studying the effectiveness of a special device called a duodenal prosthesis, which is used to treat narrowing (stenosis) in the duodenum, the first part of the small intestine. This narrowing can cause problems like difficulty swallowing (dysphagia) and is often associated with certain types of tumors. The trial aims to see how well these prostheses work over a period of six years for patients who have experienced symptoms related to this condition.

To participate in the trial, individuals should be between 65 and 74 years old and must have had symptomatic duodenal stenosis treated with a duodenal prosthesis from 2010 to 2017. It's important to note that people with benign (non-cancerous) stenosis or those who have used a covered metallic prosthesis are not eligible to join. Participants can expect regular follow-ups to assess how well the treatment is working and to monitor their symptoms. This trial could provide valuable information on the long-term benefits of this treatment option for those affected by duodenal stenosis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017.
  • Exclusion Criteria:
  • Benign stenosis or covered metallic duodenal prosthesis (usually indicated for benign disease)

About Institut Paoli Calmettes

Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.

Locations

Marseille, Bouches Du Rhone, France

Patients applied

0 patients applied

Trial Officials

Fabrice CAILLOL

Principal Investigator

Institut Paoli-Calmettes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials